Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Alpan Farma Ar-Ge Biyoteknolojileri Ltd.Sti. | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the effectiveness of Hydrolyzed collagen peptides on joint pain, stiffness and physical function in adults with osteoarthritis who have complaints on knee joints together with hip and ankles. The assessment of improvements on volunteers' quality of life, and safety and tolerability of the product is the other objective of this placebo-controlled, randomized study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hydrolized Collagen Peptide | Experimental | This arm will be allocated randomly and receive 10 g hydrolized collagen peptide (Investigational Product) daily throughout the study. |
|
| Placebo | Placebo Comparator | This arm will be allocated randomly and receive placebo daily throughout the study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hydrolyzed Collagen Peptide | Dietary Supplement | Dietary Hydrolized Collagen Peptide sourced from bovine |
|
| Measure | Description | Time Frame |
|---|---|---|
| Amelioration on Knee Pain | Amelioration on knee joint pain, stiffness and physical function according to WOMAC (The Western Ontario and McMaster Universities Osteoarthritis Index) score. | 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| Amelioration on Hip Pain | Amelioration on pain, stiffness and physical function of joints of hip according to WOMAC score. | 2 months |
| Amelioration on Ankle Pain | Amelioration on pain and physical function of ankles according to AOFASAHFS (American Orthopaedic Foot and Ankle Society Ankle-Hindfoot Scale) scale. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Aydın Erenmemişoğlu, Prof. Dr. | Contact | +90 532 551 0082 | aydin@alpanfarma.com |
Not provided
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40507417 | Derived | Demir-Dora D, Tuna S, Kurtoglu ED, Gursoy S, Balci N, Tezman S, Erenmemisoglu A. Evaluation of the Efficacy and Safety of CollaSel PRO(R) Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J Clin Med. 2025 May 23;14(11):3655. doi: 10.3390/jcm14113655. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018771 | Arthralgia |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
Not provided
Not provided
| ID | Term |
|---|---|
| D003094 | Collagen |
| ID | Term |
|---|---|
| D001704 | Biopolymers |
| D011108 | Polymers |
| D046911 | Macromolecular Substances |
| D016326 | Extracellular Matrix Proteins |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 months |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012596 |
| Scleroproteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |